FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.6  |  FHIR Version n/a  User: [n/a]

900000000000526001: REPLACED BY association reference set (foundation metadata concept)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT model component module (core metadata concept)

Descriptions:

Id Description Lang Type Status Case? Module
900000000001156010 REPLACED BY association reference set (foundation metadata concept) en Fully specified name Active Entire term case sensitive (core metadata concept) SNOMED CT model component module (core metadata concept)
900000000001157018 REPLACED BY association reference set en Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT model component module (core metadata concept)


10679 members. Search Members:

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
REPLACED BY association reference set (foundation metadata concept) Is a Historical association reference set (foundation metadata concept) true Inferred relationship Some

Members targetComponentId
CDC group DF-2 Capnocytophaga canimorsus
CDE genotype CDE haplotype (finding)
CDe genotype CDe haplotype (finding)
CTV3 ROOT SNOMED CT Concept
kål, livsmedel Cabbage (substance)
Cabergoline [parkinsons] Product containing cabergoline (medicinal product)
Caffeine and sodium benzoate injection Product containing caffeine and sodium benzoate (medicinal product)
koffeininnehållande substans, icke läkemedel Caffeine
café-au-lait-fläckar och ringkromosom 11 Ring chromosome 11 syndrome
kalcipotrien 0,005 %/betametason 0,064 %, suspension för lokalt bruk Product containing precisely betamethasone (as betamethasone dipropionate) 500 microgram/1 milliliter and calcipotriol 50 microgram/1 milliliter conventional release cutaneous lotion (clinical drug)
kalcitonin från lax 100 enheter/ml, injektionsvätska, lösning, flaska 1 ml Product containing precisely salmon calcitonin 100 unit/1 milliliter conventional release solution for injection (clinical drug)
laxkalcitonin 200 IE/ml, sprej Product containing precisely salmon calcitonin 200 unit/1 actuation conventional release nasal spray (clinical drug)
Calcitonin, salmon 200unt/mL injection Salmon calcitonin 200 unit/mL solution for injection
kalcitonin från lax 200 enheter/ml, injektionsvätska, lösning, flaska 2 ml Salmon calcitonin 200 unit/mL solution for injection
Calcium analyte Calcium
kalciumbaserat antacidum Calcium compound
kalciumkarbonat 1,25 g + kolekalciferol 11 mikrogram, dospåse med granulat Calcium carbonate 6.25 mg/mL and colecalciferol 2.2 unit/mL oral solution
kalciumklorid 10 %, injektionsvätska, lösning, förfylld spruta 10 ml Product containing precisely calcium chloride 100 milligram/1 milliliter conventional release solution for injection (clinical drug)
kalciumhydroxiapatit, mikrosfärsuspension i vattenbaserad bärare, förfylld spruta 0,3 ml Hydroxyapatite only product in parenteral dose form
kalciumhydroxiapatit, mikrosfärsuspension i vattenbaserad bärare, förfylld spruta 1,3 ml Hydroxyapatite only product in parenteral dose form
kalciumfosfat 3 100 mg + cholekalciferol 20 mikrogram per dospåse, pulver till oral suspension Calcium phosphate and colecalciferol only product
Calculus - composition Finding of stone composition (finding)
kalfaktant, intratraekal suspension, flaska 6 ml Product containing only calfactant (medicinal product)
Calicivirus group Family Caliciviridae (organism)
Calliphora erythrocephala Calliphora vicina
Callitrogae Genus Cochliomyia (organism)
Caloric intake, function (observable entity) Energy intake (observable entity)
Caloscypha fulgens Caloscypha fulgens (organism)
Calymmatobacterium granulomatis Klebsiella granulomatis (organism)
Campylobacter cinaedi Helicobacter cinaedi
Campylobacter fennelliae Helicobacter fennelliae
Campylobacter laridis Campylobacter lari
Campylobacter laridis rRNA Campylobacter lari rRNA
Campylobacter laridis rRNA assay Campylobacter lari rRNA assay
Campylobacter nitrofigilis Arcobacter nitrofigilis (organism)
kanakinumab 150 mg, pulver till injektionsvätska, lösning Canakinumab only product
cancervårdplan Cancer care plan
Cancer care plan Cancer care plan
Cancer care plan Cancer care plan
genomgång av cancerbehandling Cancer care review (procedure)
utförd screening för livmoderhalscancer Screening for malignant neoplasm of cervix done (situation)
Candida famata Debaryomyces hansenii
Candida famata Debaryomyces hansenii
Candida humicola Vanrija humicola (organism)
Candida krusei var. vanlaeriana Pichia membranifaciens (organism)
Candida lipolytica Yarrowia lipolytica
Candida pseudotropicalis Kluyveromyces marxianus
Candidiasis of other specified sites Candidiasis
Candidiasis of other urogenital sites Candidiasis of urogenital site
Canine cortical hyperostosis Disorder of bone (disorder)
Canis familiaris Canis lupus subspecies familiaris (organism)
Canis rufus Canis lupus subspecies rufus (organism)
Cannabinoid Cannabis (substance)
Cannabinoid - non-pharmaceutical Cannabis (substance)
kannabisgräs, icke läkemedel Cannabis (substance)
kannabisblad, icke läkemedel Cannabis leaf (substance)
kannabisolja, icke läkemedel Cannabis oil (substance)
kannabisharts, icke läkemedel Cannabis resin (substance)
Cannulation - action Insertion - action (qualifier value)
kapillära hemangiom, kategori Capillary hemangioma
Capnocytophaga canimorsus Capnocytophaga canimorsus
Caprine adenovirus Goat adenovirus (organism)
kapsaicin 179 mg/timme, depåplåster Product containing precisely capsaicin 179 milligram/1 each conventional release cutaneous patch (clinical drug)
kapsel i distal interfalangealled i stortå, struktur Structure of capsule of interphalangeal joint of great toe
kaptoprilallergi Non-allergic hypersensitivity to captopril (finding)
karbakol 1 %, ögondroppar Product containing precisely carbachol 10 milligram/1 milliliter conventional release eye solution (clinical drug)
karbakol 1,5 %, ögondroppar Carbachol 15 mg/mL eye solution
Carbachol 1.5% solution Carbachol 15 mg/mL eye solution
karbakol 250 mikrogram/ml, injektionsvätska, lösning, ampull 1 ml Product containing precisely carbachol 250 microgram/1 milliliter conventional release solution for injection (clinical drug)
karbamazepin 100 mg, kapsel med modifierad frisättning Carbamazepine only product in oral dose form
karbamazepin 100 mg, tablett med modifierad frisättning Carbamazepine only product in oral dose form
karbamazepin 100 mg, depåkapsel Carbamazepine only product in oral dose form
karbamazepin 100 mg, depåtablett Carbamazepine only product in oral dose form
karbamazepin 200 mg, kapsel med modifierad frisättning Carbamazepine only product in oral dose form
karbamazepin 200 mg, depåkapsel Carbamazepine only product in oral dose form
karbamazepin 300 mg, kapsel med modifierad frisättning Carbamazepine only product in oral dose form
karbamazepin 300 mg, depåkapsel Carbamazepine only product in oral dose form
karbenoxolonnatrium 1 %, granulat till munsköljvätska Carbenoxolone only product
karbenoxolonnatrium 2 %, oral gel Product containing precisely carbenoxolone 20 milligram/1 gram conventional release oral gel (clinical drug)
karbidopa 25 mg + levodopa 100 mg, tablett med modifierad frisättning Carbidopa 25 mg and levodopa 100 mg prolonged-release oral tablet
karbidopa 50 mg + levodopa 200 mg, tablett med modifierad frisättning Product containing precisely carbidopa 50 milligram and levodopa 200 milligram/1 each prolonged-release oral tablet (clinical drug)
karbidopa 10 mg + levodopa 100 mg, munsönderfallande tablett Product containing precisely carbidopa anhydrous (as carbidopa) 10 milligram and levodopa 100 milligram/1 each conventional release orodispersible tablet (clinical drug)
karbidopa 18,75 mg + levodopa 75 mg + entakapon 200 mg, tablett Carbidopa anhydrous (as carbidopa) 18.75 mg and entacapone 200 mg and levodopa 75 mg oral tablet
Carbidopa 25mg Product containing precisely carbidopa anhydrous (as carbidopa) 25 milligram/1 each conventional release oral tablet (clinical drug)
karbidopa 25 mg + levodopa 100 mg, munsönderfallande tablett Product containing precisely carbidopa anhydrous (as carbidopa) 25 milligram and levodopa 100 milligram/1 each conventional release orodispersible tablet (clinical drug)
karbidopa 25 mg + levodopa 250 mg, munsönderfallande tablett Carbidopa anhydrous (as carbidopa) 25 mg and levodopa 250 mg orodispersible tablet
karbidopa 31,25 mg + levodopa 125 mg + entakapon 200 mg, tablett Carbidopa anhydrous (as carbidopa) 31.25 mg and entacapone 200 mg and levodopa 125 mg oral tablet
karbinoxaminmaleat 1 mg/ml + dextrometorfanhydrobromid 4 mg/ml + pseudoefedrinhydroklorid 15 mg/ml, droppar Product containing precisely carbinoxamine maleate 1 milligram/1 milliliter and dextromethorphan hydrobromide 4 milligram/1 milliliter and pseudoephedrine hydrochloride 15 milligram/1 milliliter conventional release oral solution (clinical drug)
karbinoxaminmaleat 4 mg/5 ml + dextrometorfanhydrobromid 12,5 mg/5 ml + pseudoefedrinhydroklorid 60 mg/5 ml, sirap Product containing precisely carbinoxamine maleate 800 microgram/1 milliliter and dextromethorphan hydrobromide 2.5 milligram/1 milliliter and pseudoephedrine hydrochloride 12 milligram/1 milliliter conventional release oral solution (clinical drug)
karbinoxaminmaleat 4 mg/5 ml + dextrometorfanhydrobromid 15 mg/5 ml + pseudoefedrinhydroklorid 60 mg/5 ml, sirap Product containing precisely carbinoxamine maleate 800 microgram/1 milliliter and dextromethorphan hydrobromide 3 milligram/1 milliliter and pseudoephedrine hydrochloride 12 milligram/1 milliliter conventional release oral solution (clinical drug)
karbinoxaminmaleat 1 mg/ml+ pseudoefedrinhydroklorid 15 mg/ml, droppar Carbinoxamine maleate 1 mg/mL and pseudoephedrine hydrochloride 15 mg/mL oral solution
karbinoxaminmaleat + pseudoefedrinhydroklorid 8 mg/120 mg, tablett med modifierad frisättning Product containing only carbinoxamine and pseudoephedrine in oral dose form (medicinal product form)
karbinoxaminmaleat 8 mg + pseudoefedrinhydroklorid 120 mg, depåtablett Product containing only carbinoxamine and pseudoephedrine in oral dose form (medicinal product form)
Carbohydrate agent Carbohydrate
karbolfuksin Carbol-fuchsin (substance)
Carbon-carbon lyase Carbon-carbon lyase
Carbon-halide lyase Carbon-halide lyase
Carbon-nitrogen lyase Carbon-nitrogen lyase
Carbon-oxygen lyase Carbon-oxygen lyase
Carbon-sulfur lyase Carbon-sulfur lyase (substance)
Carboxy-lyase Decarboxylase

Start Previous Page 14 of 107 Next End


Reference Sets

Reference set descriptor

Back to Start